Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
06/2000
06/08/2000WO1999011232A8 Oral compositions
06/08/2000CA2353402A1 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same
06/08/2000CA2352454A1 Peptide-based vaccine for influenza
06/07/2000EP1006110A1 Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments
06/07/2000EP1005350A1 Composition and method of treating cancer with tannic acid and tannin complexes
06/07/2000EP1005342A1 Pharmaceutical compositions of tizoxanide and nitazoxanide
06/07/2000EP1005332A2 Pharmaceutical composition for reducing production of mcp-1 protein
06/07/2000EP1005321A2 Hair conditioner and 2-in-1 conditioning shampoo
06/07/2000CN1255849A Medical compsns.
06/06/2000US6071499 Hair shaping, styling, disentangling; feel
06/04/2000CA2291471A1 Lowering blood levels of lipoprotein(a)
06/02/2000WO2000030671A2 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto
06/02/2000WO2000030668A2 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration
06/02/2000WO2000030625A2 Use of phosphonoformic acid derivatives for treating infections
06/02/2000WO2000030616A1 Dispersible phospholipid stabilized microparticles
06/02/2000WO2000030608A1 Pressurised metered dose inhalers (mdi)
06/02/2000WO2000030607A1 PHARMACEUTICAL AEROSOL COMPOSITION CONTAINING HFA 227 AND HFA 134a
06/02/2000CA2698376A1 Pressurised metered dose inhalers (mdi)
06/02/2000CA2352599A1 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto
06/02/2000CA2352549A1 Use of phosphonoformic acid derivatives for treating infections
06/02/2000CA2352043A1 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration
05/2000
05/31/2000EP1003728A1 2- 3- 4-(2-t-butyl-6- trifluoromethylpyridin-4-yl) piperazin-1-yl] propylmercapto pyrimidin-4-ol-fumarate
05/31/2000EP1003537A1 Et
05/31/2000EP1003523A1 Method of treatment of liver tumours and pharmaceutical compositions for use therein
05/31/2000EP1003486A2 Pharmaceutical compositions containing an effervescent acid-base couple
05/31/2000EP1003468A1 Effervescent two component dentifrice
05/31/2000EP0861093B1 Non-invasive Detection of the Integration of a Transgene in Mammals
05/31/2000DE19854402A1 Verwendung von Phosphonameisensäurederivaten zur therapeutischen und prophylaktischen Behandlung von Infektionen Using Phosphonameisensäurederivaten for the therapeutic and prophylactic treatment of infections
05/31/2000CN1255066A Plant extracts for the treatment of increase bone resorption
05/31/2000CN1255060A Pharmaceutical compositions of tizoxanide and nitazoxanide
05/31/2000CN1255057A Aqueous pharmaceutical composition comprising active ingredient which is highly insoluble in water
05/31/2000CN1053012C Hog choera virus vaccine and diagnostic
05/30/2000US6069135 Use of hyaluronic acid or its derivatives to enhance delivery of therapeutic agents
05/30/2000US6068859 Controlled-release dosage forms of Azithromycin
05/25/2000WO2000029384A1 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof
05/25/2000WO2000029005A1 Method for producing an agent for treating non-cancerous pathologies of the organism
05/25/2000WO2000028979A1 Dry powder for inhalation
05/25/2000WO2000028956A1 Antiperspirant formulation for porous applicator
05/25/2000WO2000021528A8 Use of ophthalmic composition comprising vitamin a and vitamin e
05/25/2000CA2349167A1 Antiperspirant formulation for porous applicator
05/25/2000CA2348744A1 Method for producing an agent for treating non-cancerous pathologies of the organism
05/24/2000EP1002795A1 HIV Replication inhibiting pyrimidines
05/24/2000EP1002791A1 Aminoethylphenoxyacetic acid derivatives and drugs for pain remission and calculi removal promotion in urinary lithiasis
05/24/2000EP1002547A1 Hydrosoluble hedgehog protein in ionic complex and pharmaceutical use thereof
05/24/2000EP1001946A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56?1ck TYROSINE KINASES
05/24/2000EP1001945A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56?lck TYROSINE KINASES
05/24/2000EP1001797A1 Soya extract, process for its preparation and pharmaceutical composition
05/24/2000EP1001686A1 Dehydration plant
05/24/2000EP0705094B1 Skin and scalp barrier for use with hair treatment products
05/24/2000CN1254328A Process for preparing substituted 2-3-dihydro-1-indanones
05/24/2000CN1253771A Method for eliminating scabriculous and/or wrinkle and composite
05/23/2000US6066678 Alkylated and crosslinked polymer comprises the reaction product of polymers of given formula having amine containing repeat units with at least one aliphatic alkylating agent and a crosslinking agent; administering to remove bile salts
05/23/2000US6066673 Enzyme inhibitors
05/23/2000US6066092 Preemptive prophylaxis of migraine device and method
05/18/2000WO2000027825A1 Hiv replication inhibiting pyrimidines
05/18/2000WO2000027820A1 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as vegf receptor tyrosine kinase inhibitors
05/18/2000WO2000027364A1 New controlled release bead, a method of producing the same and multiple unit formulation comprising it
05/18/2000WO2000027359A1 An inhalation system
05/18/2000WO2000027338A2 Fluorinated toothpaste composition comprising calcic material abrasive particles compatible with fluorine
05/18/2000WO2000004892A3 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions
05/18/2000DE19945814A1 Verfahren zur Zubereitung eines pharmazeutischen Artemisia-Extraktes und Vorrichtung zur elektrischen Moxibustion unter Verwendung des Extraktes A process for the preparation of a pharmaceutical Artemisia extract and moxibustion device for electrically using the extract
05/18/2000CA2351063A1 A system for administering a bioactive agent by inhalation comprising a lipid mixture comprising phosphatidylcholine
05/18/2000CA2346898A1 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as vegf receptor tyrosine kinase inhibitors
05/17/2000EP1000626A1 Chemokine receptor antagonist and cyclosporin in combined therapy
05/17/2000EP1000029A1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders
05/17/2000EP1000027A1 Thermodynamically stable modification of 1-(4-carbazolyloxy)-3- 2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it
05/17/2000EP0999846A1 Phosphatidic acid-based immune modulator composition
05/17/2000EP0999841A1 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
05/17/2000EP0999830A1 Sertraline salts and sustained-release dosage forms of sertraline
05/17/2000EP0731706B1 Use of dimeticone for the manufacture of a medicament for treating aphthae and stomatitis
05/17/2000CN1253561A Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3', 5'-monophosphate phosphodiesterase (cGMP PDE5) for treatment of sexual dysfunction
05/17/2000CN1253557A Vitamin D3 analogs with bis C-20 side chains
05/17/2000CN1253551A Pyrazine compounds
05/16/2000US6063787 Methods for the treatment of psoriasis and genital warts
05/16/2000US6063361 Administering to a patient at least one cascade polymer complex and subjecting the patient to a radiology diagnosis
05/16/2000CA2013226C Cephalosporin derivatives and processes for their preparation
05/16/2000CA1340994C Treatment of conditions and disease
05/11/2000WO2000025826A1 Lactone bearing absorbable polymers
05/11/2000WO2000025778A1 5ht1 receptor agonists and metoclopramide for the treatment of migraine
05/11/2000WO2000025746A2 A process for the preparation of suspensions of drug particles for inhalation delivery
05/11/2000WO2000025724A2 COMPOSITIONS COMPRISING OLEUM $i(MELALEUCA)
05/11/2000WO2000007581A3 Antioxidant, antiproliferous composition, comprising a carnitine and a carotenoid
05/11/2000CA2349346A1 Lactone bearing absorbable polymers
05/11/2000CA2348543A1 5ht1 receptor agonists and metoclopramide for the treatment of migraine
05/10/2000EP0998906A2 Shampoo composition
05/10/2000EP0998294A1 Ganglioside gm3 induced apoptosis of neural cells
05/10/2000EP0998292A2 Method for inhibiting bone resorption
05/10/2000EP0998265A1 Benefit agent compositions comprising mixtures of alpha-hydroxy esters
05/10/2000EP0998260A1 Oxidation dyeing composition for keratin fibres and dyeing method using said composition
05/10/2000EP0998251A2 Compositions and methods for inhibiting photoaging of skin
05/10/2000CN1252809A Modified TNF alpha molecules, DNA encoding such modified TNF alpha molecules and vaccines comprising such modified TNF alpha molecules and DNA
05/10/2000CN1252808A Antipathogenic synthetic piptides and compositions comprising them
05/10/2000CN1252723A Use of 7 alpha-methyl-17 alpha-ethyle-estrane derivative for treatment of atherosclerosis
05/10/2000CN1252707A Use of unsaturated aldehydes in dying fibers containing keratin
05/09/2000CA2112239C Enantiomeric hydroxylated xanthine compounds
05/04/2000WO2000024743A1 Pyrano, piperidino, and thiopyrano compounds and methods of use
05/04/2000WO2000024710A1 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
05/04/2000WO2000024383A1 Controlled-release pharmaceutical formulations containing a cgmp pde-5 inhibitor
05/04/2000WO1999058099A3 Method for permanently shaping keratin fibres, and agents
05/04/2000CA2348576A1 Pyrano, piperidino, and thiopyrano compounds and methods of use
1 ... 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 ... 295